ACET News

Latest breaking news and updates for ACET stock.

Track all markets on TradingView

Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoim...

What are the implications of the site activation numbers for future commercial rollout? How does the reported sentiment (60) align with market sentiment and analyst ratings? What are the potential catalysts (e.g., data readout, FDA interactions) that could move the stock price?
Earnings
21 days ago
Read more businesswire

Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoim...

Is there an anticipated change in analyst coverage or rating upgrades/downgrades following the conference? Will the fireside chat reveal updates on clinical trial timelines that could influence forward‑looking earnings estimates? How might this announcement affect the competitive landscape perception versus other companies developing allogeneic γδ T‑cell therapies?
Conference
23 days ago
Read more businesswire